FDA-approved algorithms can inform clinicians of heart abnormalities

Eko, a Berkeley-based cardiac screening and monitoring company founded by UC Berkeley alumni, gained approval from the Food and Drug Administration for algorithms that screen heart murmurs and atrial fibrillation, which will pair with its artificial intelligence-powered, or AI, stethoscope.
Read More…